4//SEC Filing
Zurbay Donald 4
Accession 0001140361-24-041431
CIK 0001397702other
Filed
Sep 17, 8:00 PM ET
Accepted
Sep 18, 9:12 PM ET
Size
12.9 KB
Accession
0001140361-24-041431
Insider Transaction Report
Form 4
Zurbay Donald
Director
Transactions
- Disposition to Issuer
Common Stock
2024-09-17−12,610→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2024-09-17$21.39/sh−146,031$3,123,603→ 0 totalExercise: $6.11Exp: 2028-03-22→ Common Stock (146,031 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-09-17$15.35/sh−29,206$448,312→ 0 totalExercise: $12.15Exp: 2028-03-22→ Common Stock (29,206 underlying) - Disposition to Issuer
Stock Option (right to buy)
2024-09-17$7.50/sh−8,910$66,825→ 0 totalExercise: $20.00Exp: 2029-04-03→ Common Stock (8,910 underlying)
Footnotes (6)
- [F1]Of the reported shares, 5,859 are represented by restricted stock units, or RSUs, each of which represents a contingent right to receive one share of Issuer common stock.
- [F2]Pursuant to the Agreement and Plan of Merger dated June 17, 2024, between the Issuer, Boston Scientific Corporation and Seminole Merger Sub, Inc, (the "Merger Agreement"), each share of Issuer common stock was canceled and converted into the right to receive $27.50 per share in cash (the "Merger Consideration"), without interest and subject to applicable withholding taxes.
- [F3]Pursuant to the Merger Agreement, each RSU was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the Merger Consideration and (ii) the aggregate number of shares underlying the RSUs, less applicable taxes and authorized deductions.
- [F4]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $3,123,603.09, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
- [F5]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $448,312.10, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
- [F6]The shares subject to the option are fully vested and immediately exercisable. Pursuant to the Merger Agreement, the option was cancelled in exchange for a cash payment of $66,825.00, which represents the difference between (i) the amount by which the Merger Consideration exceeded the exercise price of the option per share option and (ii) the aggregate number of shares remaining issuable upon exercise of the option, less applicable taxes and authorized deductions.
Documents
Issuer
Silk Road Medical Inc
CIK 0001397702
Entity typeother
Related Parties
1- filerCIK 0001341608
Filing Metadata
- Form type
- 4
- Filed
- Sep 17, 8:00 PM ET
- Accepted
- Sep 18, 9:12 PM ET
- Size
- 12.9 KB